Project Grant R01HD114750
- Grant Award Summary The University of Texas Southwestern Medical Center received a $456,500 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2026 through May 31, 2028. The award funds research to characterize the molecular mechanisms of human cervical epithelial barrier function during pregnancy. The project delivers two primary research products: (1)...
- This Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) provides $649,961 to Texas A&M Engineering Experiment Station (Tees) to conduct research on how the mechanical movements of the uterus, known as peristalsis, impact the cells in the uterine lining. The research will utilize a specialized bioreactor device to investigate how uterine mechanics affect the behavior of different cell types in the endometrium, including their motility,...
- Federal Project Grant Award Summary The University of Georgia Research Foundation, Inc. received a $131,685 Project Grant award dated January 30, 2026, from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research investigating the mutual communication mechanisms between RhoA signaling and progesterone (P4) signaling in luteal cells and the uterus during early...
- Federal Project Grant Award Summary Baylor College of Medicine received a $311,488 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025, through April 16, 2028. The award funds research investigating iron homeostasis and ferroptosis mechanisms in endometriosis and early pregnancy outcomes. The research addresses a significant public health...
- Grant Award Summary The University of California, San Diego received a $600,016 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded June 1, 2026, with completion targeted for February 28, 2031. The award funds research investigating extracellular vesicles (EVs) as mediators of kidney damage in preeclampsia, a hypertensive disorder affecting 2-10% of pregnant women...
- Worcester Polytechnic Institute will develop and deliver dual-platform in vitro bioengineered models of uterine fibroids under this $555,371 Project Grant award from the National Institute of Child Health and Human Development (NICHD) through the Child Health and Human Development Extramural Research program (CFDA 93.865). The award, effective June 1, 2026, through May 31, 2029, funds research to create advanced three-dimensional tissue models with tunable transport properties and...
- Federal Project Grant Award Summary The Trustees of Tufts College received a $351,945 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2026, with completion targeted for February 28, 2031. The award funds research to investigate inflammation resolution mechanisms in endometrial health and disease, specifically examining how specialized...
- Federal Project Grant Award Summary Oregon Health & Science University received a $746,208 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded June 1, 2026, with an ultimate completion date of February 28, 2031. The project investigates the role of the corpus luteum on placental development, specifically examining how programmed frozen embryo transfers (P-FET)...
- Federal Project Grant Award Summary North Carolina State University received a $673,394 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective July 1, 2026, through March 31, 2031. The award funds research to decode the epigenetic networks orchestrating endometrial function, with specific focus on Ten-Eleven Translocation (TET) family proteins and their roles...
- Federal Project Grant Award Summary Emory University received a $609,863 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded June 23, 2026, with completion targeted for March 31, 2031. The grant supports research to investigate how menstruation impacts the durability of tissue-resident memory T cells in the female reproductive tract, with specific focus on immune...
MECHANISMS OF UTERINE FLUID ABSORPTION DURING EARLY PREGNANCY - PROJECT SUMMARY / ABSTRACT DYNAMIC UTERINE FLUID VOLUME IS ESSENTIAL FOR SUCCESSFUL EARLY PREGNANCY. UTERINE FLUID VOLUME IS THE NET RESULT OF SECRETION AND ABSORPTION, WHICH ARE RESPECTIVELY PROMOTED BY OVARIAN ESTRADIOL (E2) AND PROGESTERONE (P4) THROUGH THE UTERINE EPITHELIUM. DYSREGULATED UTERINE FLUID MOVEMENT HAS BEEN ASSOCIATED WITH IMPAIRED EARLY PREGNANCY, PARTICULARLY IN WOMEN WITH ENDOMETRIOSIS UNDERGOING OVARIAN STIMULATION FOR IN VITRO FERTILIZATION-EM- BRYO TRANSFER (IVF-ET) WHO OFTEN EXPERIENCE UTERINE FLUID RETENTION AND IMPLANTATION FAILURE. NA+ AND CL- ARE THE DOMINANT IONS IN THE UTERINE FLUID. AMILORIDE-SENSITIVE EPITHELIAL NA+ CHANNEL (ENAC) AND CYSTIC FIBROSIS TRANS- MEMBRANE CONDUCTANCE REGULATOR (CFTR) HAVE BEEN IMPLICATED IN THEIR MOVEMENTS ACROSS THE UTERINE EPITHELIAL CELL MEMBRANE TO GENERATE OSMOTIC GRADIENTS FOR FACILITATING FLUID MOVEMENT THROUGH THE EPITHELIAL MEMBRANE WATER CHANNELS, AQUAPORINS (AQPS). DESPITE THE ESSENTIAL ROLES OF SEX HORMONES AND ION/WATER CHANNELS IN REGULATING DYNAMIC UTERINE FLUID MOVEMENT DURING EARLY PREGNANCY, THE PRECISE HORMONAL AND IONIC MECHANISMS REMAINS ELUSIVE. OUR PRELIMINARY DATA IN MOUSE MODELS REVEALED INHIBITION OF UTERINE FLUID ABSORPTION BY AMILORIDE ON DAY 0.5 POST-COITUS (D0.5) BUT NOT D3.5, DYNAMIC EXPRESSION OF GENES FOR ION/WATER CHANNELS IN D0.5 AND D3.5 LUMINAL EPITHELIUM (EMBRYO IMPLANTATION INITIATES ~D4.0 IN MICE) BY MRNA-SEQ, AND A NOVEL FUNCTION OF E2-ES- TROGEN RECEPTOR A (ERA) IN REGULATING UTERINE FLUID ABSORPTION. IN HUMAN MODELS, WE DEVELOPED A MICROPHYSIO- LOGICAL SYSTEM THAT ENABLES A MICROFLUIDIC CO-CULTURE OF OVARIAN FOLLICLES AND HUMAN ENDOMETRIAL (ENDO) ORGANOIDS FOR ENGINEERING A FEMALE REPRODUCTIVE TRACT-ON-A-CHIP (FRT-CHIP), AND OUR PRELIMINARY DATA SHOWED THE LONG- TERM SURVIVAL AND 3D ARCHITECTURE OF ENDO ORGANOIDS IN VITRO AS WELL AS THE REGULATION OF ENAC AND CFTR BY CO- CULTURED FOLLICLES. HEREIN, WE FORMULATE OUR CENTRAL HYPOTHESIS THAT ERA AND PR CONVERGE ON HORMONAL AND IONIC MECHANISMS TO FINELY COORDINATE TEMPORAL UTERINE FLUID ABSORPTION DURING EARLY PREGNANCY, WHILE DYSREGULATION OF ION/WATER CHANNELS IN EUTOPIC ENDOMETRIOSIS ENDOMETRIUM OR UNDER OVARIAN STIMULATION FOR IVF LEADS TO DISRUPTED UTERINE FLUID DYNAMICS AND IMPAIRED EARLY PREGNANCY. THERE ARE TWO SPECIFIC AIMS. IN AIM 1, WE WILL USE TRANS- GENIC MOUSE MODELS WITH ERA OR PR DEFICIENCY IN THE UTERINE EPITHELIUM TO DETERMINE IN VIVO FUNCTIONS AND REGULATORY MECHANISMS OF SELECTED NA+ CHANNELS, CL- CHANNELS, AND WATER CHANNELS IN THE UTERINE EPITHELIUM FOR UTERINE FLUID ABSORPTION DURING EARLY PREGNANCY. IN AIM 2, WE WILL COLLECT NORMAL AND ENDOMETRIOSIS ENDOMETRIUM BIOPSIES FROM MENSTRUATING WOMEN AND IVF-ET PATIENTS TO COMPARE ION/WATER CHANNELS IN HUMAN ENDOMETRIUM BIOPSIES AND PERFORM A MICROFLUIDIC CO-CULTURE OF FOLLICLES AND ENDO ORGANOIDS TO ENGINEER AN FRT-CHIP AND INVESTIGATE MECHANISMS REGULATING HUMAN UTERINE FLUID MOVEMENT UNDER PHYSIOLOGICAL AND PATHOLOGICAL CONDI- TIONS. THE SUCCESSFUL COMPLETION OF THESE STUDIES WILL GENERATE A COMPREHENSIVE MOLECULAR ATLAS OF UTERINE FLUID MOVEMENT. IDENTIFICATION OF LOCAL UTERINE EPITHELIAL FACTORS IS A CRUCIAL FIRST STEP FOR DEVELOPING TREATMENTS TO REG- ULATE UTERINE FLUID MOVEMENT, IMPROVE EMBRYO IMPLANTATION SUCCESS, AND REDUCE EARLY PREGNANCY LOSS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $637.5k | 3/24/26 | ||
| Not listed | $648.3k | 4/4/25 | ||
| Not listed | $685.2k | 6/25/24 | ||
| Not listed | $685.2k | 6/25/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
SUB00003565S | Rutgers, The State University | Project Grant R01HD114750 | $184.1k | 6/4/26 | |
SUB00003564S | The Johns Hopkins University | Project Grant R01HD114750 | $188.2k | 6/4/26 | |
SUB00003564S | The Johns Hopkins University | Project Grant R01HD114750 | $191.0k | 6/4/25 | |
SUB00003565S | Rutgers, The State University | Project Grant R01HD114750 | $368.2k | 5/21/25 | |
SUB00003564S | The Johns Hopkins University | Project Grant R01HD114750 | $204.4k | 11/25/24 |